INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "ENGINEERED CELLS EXPRESSING MODIFIED HLA-E POLYPEPTIDE"

GENEVA, Aug. 18 -- ASTRAZENECA AB (SE-151-85Sodertalje) filed a patent application (PCT/EP2025/053077) for "ENGINEERED CELLS EXPRESSING MODIFIED HLA-E POLYPEPTIDE" on Feb 06, 2025. With publication no. WO/2025/168691, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DU, Lijuan (AstraZeneca Pharmaceuticals LP,1800 Concord Pike,P.O. Box 15437Wilmington, Delaware 19850-5437), GUO, Zengli (AstraZeneca Pharmaceuticals LP1800 Concord Pike,P.O. Box 15437Wilmington, Delaware 19850-5437), WILSON, Susan (MEDIMMUNE, LLCOne MedImmune ...